-
401
Part II.: Dissimilar friction stir welding of nickel titanium shape memory alloy to stainless steel – microstructure, mechanical and corrosion behavior
Published 2021“…</p><h2>Other Information</h2><p dir="ltr">Published in: Journal of Advanced Joining Processes<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.jajp.2021.100072" target="_blank">https://dx.doi.org/10.1016/j.jajp.2021.100072</a></p>…”
-
402
An ensemble-based machine learning model for predicting type 2 diabetes and its effect on bone health
Published 2024“…No significant negative impact of diabetes progression on bone health was observed over a period of 5-15 yrs in the cohort.</p><h3>Conclusion</h3><p dir="ltr">This study recommends the inclusion of ML model which combines both DXA and clinical data for the early diagnosis of diabetes.…”
-
403
-
404
Characterizing the Protein Coding RNAs (mRNA) and Long Non-Coding RNAs (LncRNAs) in Chemo Resistant Triple Negative Breast Cancer
Published 2023“…Although, death rates due to BC have consistently decreased over time, TNBC still poses a challenge due to its poor prognosis, high rates of relapse and resistance to chemotherapy. …”
-
405
-
406
Visible Light Photocatalytic Activity of Ag/WO<sub>3</sub> Nanoparticles and its Antibacterial Activity Under Ambient Light and in The Dark
Published 2022“…Ultraviolet–visible spectra analysis observed a large redshift in the absorbing band edge and decreased bandgap energy from 2.6 to 2.1 eV. …”
-
407
-
408
-
409
-
410
-
411
-
412
-
413
-
414
-
415
Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans
Published 2021“…Our innovative approach applying this in vivo model to a multi-step drug repurposing screen, with artificial intelligence-driven in silico and in vitro methods, resulted in the discovery of at least one drug that may be repurposed as a disease-modifying therapy for Parkinson’s disease.…”
-
416